Plasma biomarker and machine learning modeling of clinical progression in cognitively normal individuals at risk for Alzheimer's disease.

Thabtah F, Kamalov F, Spencer R, Abdelhamid N, Nami M, Alzheimer’s Disease Neuroimaging Initiative.

Open source

DOI
10.1080/17582024.2026.2731194
Published
2026-09-20
Container
Neurodegener Dis Manag
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17582024.2026.2731194,
  title = {Plasma biomarker and machine learning modeling of clinical progression in cognitively normal individuals at risk for Alzheimer's disease.},
  author = {Thabtah F and  Kamalov F and  Spencer R and  Abdelhamid N and  Nami M and  Alzheimer’s Disease Neuroimaging Initiative.},
  year = {2026},
  journal = {Neurodegener Dis Manag},
  doi = {10.1080/17582024.2026.2731194},
  url = {https://doi.org/10.1080/17582024.2026.2731194}
}

RIS

TY  - JOUR
TI  - Plasma biomarker and machine learning modeling of clinical progression in cognitively normal individuals at risk for Alzheimer's disease.
AU  - Thabtah F
AU  -  Kamalov F
AU  -  Spencer R
AU  -  Abdelhamid N
AU  -  Nami M
AU  -  Alzheimer’s Disease Neuroimaging Initiative.
PY  - 2026
JO  - Neurodegener Dis Manag
DO  - 10.1080/17582024.2026.2731194
UR  - https://doi.org/10.1080/17582024.2026.2731194
ER  - 

APA

F, T., F, K., R, S., N, A., M, N., & Initiative., A. D. N. (2026). Plasma biomarker and machine learning modeling of clinical progression in cognitively normal individuals at risk for Alzheimer's disease.. Neurodegener Dis Manag. https://doi.org/10.1080/17582024.2026.2731194

Source records